Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) closed the day trading at $33.49 down -4.10% from the previous closing price of $34.92. In other words, the price has decreased by -$4.10 from its previous closing price. On the day, 0.75 million shares were traded. HRMY stock price reached its highest trading level at $34.9389 during the session, while it also had its lowest trading level at $33.33.
Ratios:
For a better understanding of HRMY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.67. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.28.
On September 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $56.
On June 21, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $48.Citigroup initiated its Buy rating on June 21, 2024, with a $48 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 01 ’24 when Valor IV Pharma Holdings, LLC sold 4,000,000 shares for $30.30 per share. The transaction valued at 121,210,000 led to the insider holds 7,218,033 shares of the business.
Valor IV Pharma Holdings, LLC sold 600,000 shares of HRMY for $18,181,500 on Nov 05 ’24. The 10% Owner now owns 6,618,033 shares after completing the transaction at $30.30 per share. On Nov 01 ’24, another insider, Marshman Fund Trust II, who serves as the 10% Owner of the company, sold 4,000,000 shares for $30.30 each. As a result, the insider received 121,210,000 and left with 6,651,120 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRMY now has a Market Capitalization of 1991533184 and an Enterprise Value of 1684744192. As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.85, and their Forward P/E ratio for the next fiscal year is 10.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 3.20. Its current Enterprise Value per Revenue stands at 2.471 whereas that against EBITDA is 8.442.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $41.61, while it has fallen to a 52-week low of $28.14. The 50-Day Moving Average of the stock is -4.14%, while the 200-Day Moving Average is calculated to be 1.44%.
Shares Statistics:
Over the past 3-months, HRMY traded about 750.51K shares per day on average, while over the past 10 days, HRMY traded about 415170 shares per day. A total of 57.03M shares are outstanding, with a floating share count of 40.49M. Insiders hold about 29.00% of the company’s shares, while institutions hold 66.01% stake in the company. Shares short for HRMY as of 1731628800 were 5798106 with a Short Ratio of 7.73, compared to 1728950400 on 7452511. Therefore, it implies a Short% of Shares Outstanding of 5798106 and a Short% of Float of 44.849998.
